Cargando…
The Expression of MicroRNA-21 in Bone Marrow Fluid is an Indicator of Hematological Disorders and Mortality
OBJECTIVE: Bone marrow fluid (BMF) consists of various components that establishes a microenvironment for cell differentiation and remodeling. MicroRNA-21 (miR-21) levels have recently emerged as novel biomarkers for different diseases. However, the conventional RNU6B (U6), used as the reference for...
Autores principales: | Chang, Wei-Ting, Huang, Tzu-Ling, Chen, Zhih-Cherng, Feng, Yin-Hsun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798149/ https://www.ncbi.nlm.nih.gov/pubmed/33112535 http://dx.doi.org/10.31557/APJCP.2020.21.10.2817 |
Ejemplares similares
-
The impact of COVID-19 on cardio-oncology care in Taiwan
por: Kang, Nai-Wen, et al.
Publicado: (2022) -
Deletion of MicroRNA-21 Impairs Neovascularization Following Limb Ischemia: From Bedside to Bench
por: Chang, Wei-Ting, et al.
Publicado: (2022) -
MicroRNA124 and microRNA21-5p regulate migration, proliferation and differentiation of rat bone marrow mesenchymal stem cells
por: Liu, Yan, et al.
Publicado: (2020) -
Circulating erythroblast abnormality associated with systemic pathologies may indicate bone marrow damage
por: Schreier, Stefan, et al.
Publicado: (2021) -
MicroRNA-21 inhibits p57(Kip2) expression in prostate cancer
por: Mishra, Sweta, et al.
Publicado: (2014)